Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.
暂无分享，去创建一个
S. Steinberg | B. Turkbey | R. Braylan | J. Trepel | M. Stetler-Stevenson | W. Figg | K. Calvo | Min-Jung Lee | Hao-Wei Wang | Weixin Wang | Sunmin Lee | I. Maric | M. Bhutani | E. Mena | O. Landgren | N. Korde | S. Mailankody | E. Manasanch | C. Yuan | D. Kazandjian | M. Roschewski | M. Kwok | N. Tageja | L. Lindenberg | Peter Choyke | Alina Dulau‐Florea | E. Hill | Candis Morrison | Alexander Dew | Joseph Roswarski | Yong Zhang | M. Emanuel | Ani Petrosyan | Nisha Patel